nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—primary biliary cirrhosis—liver cancer	0.432	1	CtDrD
Chenodeoxycholic acid—NR1H4—liver cancer	0.361	1	CbGaD
Chenodeoxycholic acid—UGT2B7—Epirubicin—liver cancer	0.0802	0.874	CbGbCtD
Chenodeoxycholic acid—NR1H4—bile duct—liver cancer	0.0141	0.467	CbGeAlD
Chenodeoxycholic acid—NR1H4—bile—liver cancer	0.0108	0.359	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Sorafenib—liver cancer	0.00722	0.0786	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—liver cancer	0.00438	0.0477	CbGbCtD
Chenodeoxycholic acid—NR1H4—gall bladder—liver cancer	0.003	0.0996	CbGeAlD
Chenodeoxycholic acid—Ursodeoxycholic acid—NR1H4—liver cancer	0.00207	0.893	CrCbGaD
Chenodeoxycholic acid—NR1H4—liver—liver cancer	0.00088	0.0292	CbGeAlD
Chenodeoxycholic acid—CYP27A1—liver—liver cancer	0.00064	0.0213	CbGeAlD
Chenodeoxycholic acid—UGT2B7—liver—liver cancer	0.000567	0.0188	CbGeAlD
Chenodeoxycholic acid—Ursodeoxycholic acid—CYP2E1—liver cancer	0.000247	0.107	CrCbGaD
Chenodeoxycholic acid—CYP3A4—liver—liver cancer	0.000155	0.00513	CbGeAlD
Chenodeoxycholic acid—Photosensitivity—Doxorubicin—liver cancer	9.35e-05	0.0022	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Sorafenib—liver cancer	9.33e-05	0.0022	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Sorafenib—liver cancer	9.33e-05	0.0022	CcSEcCtD
Chenodeoxycholic acid—Renal impairment—Epirubicin—liver cancer	9.33e-05	0.0022	CcSEcCtD
Chenodeoxycholic acid—Cardiac failure—Epirubicin—liver cancer	9.1e-05	0.00214	CcSEcCtD
Chenodeoxycholic acid—Cerebrovascular accident—Epirubicin—liver cancer	9.06e-05	0.00213	CcSEcCtD
Chenodeoxycholic acid—Cardiac failure congestive—Doxorubicin—liver cancer	9.06e-05	0.00213	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal haemorrhage—Epirubicin—liver cancer	8.88e-05	0.00209	CcSEcCtD
Chenodeoxycholic acid—Diplopia—Epirubicin—liver cancer	8.88e-05	0.00209	CcSEcCtD
Chenodeoxycholic acid—Migraine—Epirubicin—liver cancer	8.74e-05	0.00206	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Sorafenib—liver cancer	8.7e-05	0.00205	CcSEcCtD
Chenodeoxycholic acid—Renal impairment—Doxorubicin—liver cancer	8.63e-05	0.00203	CcSEcCtD
Chenodeoxycholic acid—Face oedema—Epirubicin—liver cancer	8.57e-05	0.00202	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Sorafenib—liver cancer	8.47e-05	0.002	CcSEcCtD
Chenodeoxycholic acid—Cardiac failure—Doxorubicin—liver cancer	8.42e-05	0.00198	CcSEcCtD
Chenodeoxycholic acid—Cerebrovascular accident—Doxorubicin—liver cancer	8.38e-05	0.00197	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Sorafenib—liver cancer	8.35e-05	0.00197	CcSEcCtD
Chenodeoxycholic acid—Blood creatinine increased—Epirubicin—liver cancer	8.32e-05	0.00196	CcSEcCtD
Chenodeoxycholic acid—Dehydration—Epirubicin—liver cancer	8.25e-05	0.00194	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	8.21e-05	0.00194	CcSEcCtD
Chenodeoxycholic acid—Diplopia—Doxorubicin—liver cancer	8.21e-05	0.00194	CcSEcCtD
Chenodeoxycholic acid—Liver function test abnormal—Epirubicin—liver cancer	8.19e-05	0.00193	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain upper—Epirubicin—liver cancer	8.11e-05	0.00191	CcSEcCtD
Chenodeoxycholic acid—Orthostatic hypotension—Epirubicin—liver cancer	8.11e-05	0.00191	CcSEcCtD
Chenodeoxycholic acid—Migraine—Doxorubicin—liver cancer	8.08e-05	0.0019	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC11A2—liver cancer	8.08e-05	0.002	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Sorafenib—liver cancer	8.08e-05	0.0019	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	8.03e-05	0.00199	CbGpPWpGaD
Chenodeoxycholic acid—Breast disorder—Epirubicin—liver cancer	8.02e-05	0.00189	CcSEcCtD
Chenodeoxycholic acid—Aspartate aminotransferase increased—Epirubicin—liver cancer	7.99e-05	0.00188	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	7.98e-05	0.00198	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—HPGDS—liver cancer	7.97e-05	0.00197	CbGpPWpGaD
Chenodeoxycholic acid—Face oedema—Doxorubicin—liver cancer	7.93e-05	0.00187	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—liver cancer	7.93e-05	0.00196	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTM1—liver cancer	7.9e-05	0.00195	CbGpPWpGaD
Chenodeoxycholic acid—Gastritis—Epirubicin—liver cancer	7.86e-05	0.00185	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Epirubicin—liver cancer	7.83e-05	0.00184	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Sorafenib—liver cancer	7.81e-05	0.00184	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC40A1—liver cancer	7.71e-05	0.00191	CbGpPWpGaD
Chenodeoxycholic acid—Blood creatinine increased—Doxorubicin—liver cancer	7.69e-05	0.00181	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7.69e-05	0.0019	CbGpPWpGaD
Chenodeoxycholic acid—Asthma—Epirubicin—liver cancer	7.67e-05	0.00181	CcSEcCtD
Chenodeoxycholic acid—Influenza—Epirubicin—liver cancer	7.67e-05	0.00181	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Epirubicin—liver cancer	7.67e-05	0.00181	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—UGDH—liver cancer	7.67e-05	0.0019	CbGpPWpGaD
Chenodeoxycholic acid—Dehydration—Doxorubicin—liver cancer	7.64e-05	0.0018	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.62e-05	0.00189	CbGpPWpGaD
Chenodeoxycholic acid—Liver function test abnormal—Doxorubicin—liver cancer	7.58e-05	0.00179	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Epirubicin—liver cancer	7.52e-05	0.00177	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Sorafenib—liver cancer	7.51e-05	0.00177	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain upper—Doxorubicin—liver cancer	7.5e-05	0.00177	CcSEcCtD
Chenodeoxycholic acid—Orthostatic hypotension—Doxorubicin—liver cancer	7.5e-05	0.00177	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP1A1—liver cancer	7.49e-05	0.00185	CbGpPWpGaD
Chenodeoxycholic acid—Angina pectoris—Epirubicin—liver cancer	7.47e-05	0.00176	CcSEcCtD
Chenodeoxycholic acid—Rash—Sorafenib—liver cancer	7.44e-05	0.00175	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Sorafenib—liver cancer	7.44e-05	0.00175	CcSEcCtD
Chenodeoxycholic acid—Breast disorder—Doxorubicin—liver cancer	7.42e-05	0.00175	CcSEcCtD
Chenodeoxycholic acid—Aspartate aminotransferase increased—Doxorubicin—liver cancer	7.4e-05	0.00174	CcSEcCtD
Chenodeoxycholic acid—Headache—Sorafenib—liver cancer	7.4e-05	0.00174	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP7B—liver cancer	7.39e-05	0.00183	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ANXA2—liver cancer	7.39e-05	0.00183	CbGpPWpGaD
Chenodeoxycholic acid—Bronchitis—Epirubicin—liver cancer	7.38e-05	0.00174	CcSEcCtD
Chenodeoxycholic acid—Gastritis—Doxorubicin—liver cancer	7.27e-05	0.00171	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Doxorubicin—liver cancer	7.24e-05	0.00171	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—liver cancer	7.22e-05	0.00179	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—EPT1—liver cancer	7.21e-05	0.00178	CbGpPWpGaD
Chenodeoxycholic acid—Dysuria—Epirubicin—liver cancer	7.17e-05	0.00169	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	7.17e-05	0.00177	CbGpPWpGaD
Chenodeoxycholic acid—Upper respiratory tract infection—Epirubicin—liver cancer	7.13e-05	0.00168	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Doxorubicin—liver cancer	7.1e-05	0.00167	CcSEcCtD
Chenodeoxycholic acid—Influenza—Doxorubicin—liver cancer	7.1e-05	0.00167	CcSEcCtD
Chenodeoxycholic acid—Asthma—Doxorubicin—liver cancer	7.1e-05	0.00167	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Epirubicin—liver cancer	7.09e-05	0.00167	CcSEcCtD
Chenodeoxycholic acid—Nausea—Sorafenib—liver cancer	7.01e-05	0.00165	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Epirubicin—liver cancer	7e-05	0.00165	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Epirubicin—liver cancer	6.98e-05	0.00165	CcSEcCtD
Chenodeoxycholic acid—Pancreatitis—Doxorubicin—liver cancer	6.96e-05	0.00164	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Epirubicin—liver cancer	6.94e-05	0.00164	CcSEcCtD
Chenodeoxycholic acid—Angina pectoris—Doxorubicin—liver cancer	6.91e-05	0.00163	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	6.88e-05	0.0017	CbGpPWpGaD
Chenodeoxycholic acid—Pneumonia—Epirubicin—liver cancer	6.88e-05	0.00162	CcSEcCtD
Chenodeoxycholic acid—Infestation—Epirubicin—liver cancer	6.84e-05	0.00161	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Epirubicin—liver cancer	6.84e-05	0.00161	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—TAT—liver cancer	6.83e-05	0.00169	CbGpPWpGaD
Chenodeoxycholic acid—Bronchitis—Doxorubicin—liver cancer	6.83e-05	0.00161	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GGT1—liver cancer	6.8e-05	0.00168	CbGpPWpGaD
Chenodeoxycholic acid—Renal failure—Epirubicin—liver cancer	6.72e-05	0.00158	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.72e-05	0.00166	CbGpPWpGaD
Chenodeoxycholic acid—Jaundice—Epirubicin—liver cancer	6.67e-05	0.00157	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Epirubicin—liver cancer	6.65e-05	0.00157	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Epirubicin—liver cancer	6.65e-05	0.00157	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Doxorubicin—liver cancer	6.64e-05	0.00156	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—liver cancer	6.61e-05	0.00163	CbGpPWpGaD
Chenodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—liver cancer	6.6e-05	0.00155	CcSEcCtD
Chenodeoxycholic acid—Sweating—Epirubicin—liver cancer	6.56e-05	0.00155	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Doxorubicin—liver cancer	6.56e-05	0.00155	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	6.52e-05	0.00161	CbGpPWpGaD
Chenodeoxycholic acid—Haematuria—Epirubicin—liver cancer	6.52e-05	0.00154	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP2E1—liver cancer	6.5e-05	0.00161	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity reaction—Doxorubicin—liver cancer	6.48e-05	0.00153	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Epirubicin—liver cancer	6.47e-05	0.00152	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Doxorubicin—liver cancer	6.46e-05	0.00152	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Epirubicin—liver cancer	6.45e-05	0.00152	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Doxorubicin—liver cancer	6.42e-05	0.00151	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Epirubicin—liver cancer	6.42e-05	0.00151	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP2E1—liver cancer	6.41e-05	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—liver cancer	6.37e-05	0.0015	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	6.36e-05	0.00157	CbGpPWpGaD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—liver cancer	6.33e-05	0.00149	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—liver cancer	6.33e-05	0.00149	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—APC—liver cancer	6.25e-05	0.00155	CbGpPWpGaD
Chenodeoxycholic acid—Renal failure—Doxorubicin—liver cancer	6.22e-05	0.00147	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Epirubicin—liver cancer	6.17e-05	0.00145	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—liver cancer	6.17e-05	0.00145	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Epirubicin—liver cancer	6.16e-05	0.00145	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—liver cancer	6.15e-05	0.00145	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—liver cancer	6.15e-05	0.00145	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Epirubicin—liver cancer	6.14e-05	0.00145	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTP1—liver cancer	6.11e-05	0.00151	CbGpPWpGaD
Chenodeoxycholic acid—Pharyngitis—Epirubicin—liver cancer	6.09e-05	0.00144	CcSEcCtD
Chenodeoxycholic acid—Sweating—Doxorubicin—liver cancer	6.07e-05	0.00143	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Epirubicin—liver cancer	6.06e-05	0.00143	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Epirubicin—liver cancer	6.05e-05	0.00143	CcSEcCtD
Chenodeoxycholic acid—Haematuria—Doxorubicin—liver cancer	6.03e-05	0.00142	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Epirubicin—liver cancer	6.03e-05	0.00142	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—HMOX1—liver cancer	6.03e-05	0.00149	CbGpPWpGaD
Chenodeoxycholic acid—Urethral disorder—Epirubicin—liver cancer	6.02e-05	0.00142	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP1A1—liver cancer	6e-05	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—liver cancer	5.99e-05	0.00141	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—liver cancer	5.97e-05	0.00141	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GGT1—liver cancer	5.97e-05	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—HNF4A—liver cancer	5.96e-05	0.00147	CbGpPWpGaD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—liver cancer	5.94e-05	0.0014	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Epirubicin—liver cancer	5.92e-05	0.00139	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	5.77e-05	0.00143	CbGpPWpGaD
Chenodeoxycholic acid—Eye disorder—Epirubicin—liver cancer	5.74e-05	0.00135	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Epirubicin—liver cancer	5.73e-05	0.00135	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—liver cancer	5.71e-05	0.00135	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Epirubicin—liver cancer	5.7e-05	0.00134	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—liver cancer	5.7e-05	0.00134	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—liver cancer	5.68e-05	0.00134	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—liver cancer	5.64e-05	0.00133	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.62e-05	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—HGF—liver cancer	5.62e-05	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTM1—liver cancer	5.62e-05	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—liver cancer	5.61e-05	0.00132	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—UGDH—liver cancer	5.6e-05	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—liver cancer	5.6e-05	0.00132	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—liver cancer	5.58e-05	0.00132	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Epirubicin—liver cancer	5.57e-05	0.00131	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—liver cancer	5.57e-05	0.00131	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Epirubicin—liver cancer	5.55e-05	0.00131	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Epirubicin—liver cancer	5.53e-05	0.0013	CcSEcCtD
Chenodeoxycholic acid—Chills—Epirubicin—liver cancer	5.51e-05	0.0013	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Epirubicin—liver cancer	5.49e-05	0.00129	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—liver cancer	5.48e-05	0.00129	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—liver cancer	5.46e-05	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	5.46e-05	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—Alopecia—Epirubicin—liver cancer	5.43e-05	0.00128	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTP1—liver cancer	5.36e-05	0.00133	CbGpPWpGaD
Chenodeoxycholic acid—Malnutrition—Epirubicin—liver cancer	5.35e-05	0.00126	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—liver cancer	5.31e-05	0.00125	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—liver cancer	5.3e-05	0.00125	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—EXOSC2—liver cancer	5.29e-05	0.00131	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTP1—liver cancer	5.29e-05	0.00131	CbGpPWpGaD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—liver cancer	5.27e-05	0.00124	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—EPT1—liver cancer	5.27e-05	0.0013	CbGpPWpGaD
Chenodeoxycholic acid—Flatulence—Epirubicin—liver cancer	5.27e-05	0.00124	CcSEcCtD
Chenodeoxycholic acid—Tension—Epirubicin—liver cancer	5.25e-05	0.00124	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Epirubicin—liver cancer	5.19e-05	0.00122	CcSEcCtD
Chenodeoxycholic acid—Back pain—Epirubicin—liver cancer	5.17e-05	0.00122	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	5.16e-05	0.00128	CbGpPWpGaD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—liver cancer	5.15e-05	0.00121	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Epirubicin—liver cancer	5.14e-05	0.00121	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—liver cancer	5.13e-05	0.00121	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—liver cancer	5.12e-05	0.00121	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—liver cancer	5.1e-05	0.0012	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—liver cancer	5.08e-05	0.0012	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.03e-05	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—Alopecia—Doxorubicin—liver cancer	5.02e-05	0.00118	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—TAT—liver cancer	4.99e-05	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—Ill-defined disorder—Epirubicin—liver cancer	4.96e-05	0.00117	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—liver cancer	4.95e-05	0.00117	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Epirubicin—liver cancer	4.94e-05	0.00116	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTM1—liver cancer	4.93e-05	0.00122	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.91e-05	0.00122	CbGpPWpGaD
Chenodeoxycholic acid—Flatulence—Doxorubicin—liver cancer	4.87e-05	0.00115	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTM1—liver cancer	4.86e-05	0.0012	CbGpPWpGaD
Chenodeoxycholic acid—Tension—Doxorubicin—liver cancer	4.85e-05	0.00114	CcSEcCtD
Chenodeoxycholic acid—Malaise—Epirubicin—liver cancer	4.82e-05	0.00114	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—liver cancer	4.8e-05	0.00113	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Epirubicin—liver cancer	4.8e-05	0.00113	CcSEcCtD
Chenodeoxycholic acid—Syncope—Epirubicin—liver cancer	4.79e-05	0.00113	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Epirubicin—liver cancer	4.78e-05	0.00113	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—liver cancer	4.78e-05	0.00113	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—liver cancer	4.76e-05	0.00112	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Epirubicin—liver cancer	4.72e-05	0.00111	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Epirubicin—liver cancer	4.7e-05	0.00111	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—UGDH—liver cancer	4.69e-05	0.00116	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP1A1—liver cancer	4.67e-05	0.00116	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Epirubicin—liver cancer	4.66e-05	0.0011	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GLUL—liver cancer	4.65e-05	0.00115	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CPT1B—liver cancer	4.65e-05	0.00115	CbGpPWpGaD
Chenodeoxycholic acid—Convulsion—Epirubicin—liver cancer	4.63e-05	0.00109	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Epirubicin—liver cancer	4.62e-05	0.00109	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP1A1—liver cancer	4.61e-05	0.00114	CbGpPWpGaD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—liver cancer	4.59e-05	0.00108	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—liver cancer	4.57e-05	0.00108	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Epirubicin—liver cancer	4.55e-05	0.00107	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Epirubicin—liver cancer	4.55e-05	0.00107	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Epirubicin—liver cancer	4.55e-05	0.00107	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	4.52e-05	0.00106	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Epirubicin—liver cancer	4.5e-05	0.00106	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—NR1H4—liver cancer	4.48e-05	0.00111	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Doxorubicin—liver cancer	4.46e-05	0.00105	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Epirubicin—liver cancer	4.45e-05	0.00105	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Doxorubicin—liver cancer	4.44e-05	0.00105	CcSEcCtD
Chenodeoxycholic acid—Syncope—Doxorubicin—liver cancer	4.44e-05	0.00105	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—liver cancer	4.43e-05	0.00104	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTA3—liver cancer	4.4e-05	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Epirubicin—liver cancer	4.4e-05	0.00104	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Doxorubicin—liver cancer	4.37e-05	0.00103	CcSEcCtD
Chenodeoxycholic acid—Oedema—Epirubicin—liver cancer	4.36e-05	0.00103	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—liver cancer	4.35e-05	0.00102	CcSEcCtD
Chenodeoxycholic acid—Infection—Epirubicin—liver cancer	4.33e-05	0.00102	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—liver cancer	4.32e-05	0.00102	CcSEcCtD
Chenodeoxycholic acid—Shock—Epirubicin—liver cancer	4.29e-05	0.00101	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	4.29e-05	0.00106	CbGpPWpGaD
Chenodeoxycholic acid—Convulsion—Doxorubicin—liver cancer	4.29e-05	0.00101	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Epirubicin—liver cancer	4.28e-05	0.00101	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Epirubicin—liver cancer	4.27e-05	0.00101	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Doxorubicin—liver cancer	4.27e-05	0.00101	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Epirubicin—liver cancer	4.26e-05	0.001	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Epirubicin—liver cancer	4.24e-05	0.000998	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Epirubicin—liver cancer	4.22e-05	0.000994	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—liver cancer	4.21e-05	0.000992	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—liver cancer	4.21e-05	0.000992	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—liver cancer	4.21e-05	0.000992	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	4.18e-05	0.000985	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—liver cancer	4.16e-05	0.00098	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Epirubicin—liver cancer	4.16e-05	0.00098	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR1I3—liver cancer	4.14e-05	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—liver cancer	4.12e-05	0.00097	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Epirubicin—liver cancer	4.08e-05	0.000961	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Doxorubicin—liver cancer	4.07e-05	0.000959	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—liver cancer	4.04e-05	0.000951	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTA4—liver cancer	4.03e-05	0.000996	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Doxorubicin—liver cancer	4.01e-05	0.000945	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Epirubicin—liver cancer	3.97e-05	0.000937	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—liver cancer	3.97e-05	0.000936	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—liver cancer	3.96e-05	0.000933	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—liver cancer	3.95e-05	0.000931	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Epirubicin—liver cancer	3.95e-05	0.00093	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—liver cancer	3.94e-05	0.000928	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.94e-05	0.000974	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTA2—liver cancer	3.93e-05	0.000971	CbGpPWpGaD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—liver cancer	3.92e-05	0.000924	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Epirubicin—liver cancer	3.92e-05	0.000923	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—liver cancer	3.9e-05	0.000919	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Epirubicin—liver cancer	3.89e-05	0.000916	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Epirubicin—liver cancer	3.88e-05	0.000914	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—liver cancer	3.85e-05	0.000907	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Epirubicin—liver cancer	3.84e-05	0.000905	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Epirubicin—liver cancer	3.79e-05	0.000894	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTA1—liver cancer	3.79e-05	0.000937	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Doxorubicin—liver cancer	3.77e-05	0.000889	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Epirubicin—liver cancer	3.77e-05	0.000887	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Epirubicin—liver cancer	3.76e-05	0.000886	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—NAT2—liver cancer	3.74e-05	0.000926	CbGpPWpGaD
Chenodeoxycholic acid—Constipation—Epirubicin—liver cancer	3.73e-05	0.000879	CcSEcCtD
Chenodeoxycholic acid—Pain—Epirubicin—liver cancer	3.73e-05	0.000879	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—liver cancer	3.68e-05	0.000867	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.68e-05	0.000909	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Doxorubicin—liver cancer	3.65e-05	0.00086	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—liver cancer	3.62e-05	0.000854	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.6e-05	0.000891	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—liver cancer	3.6e-05	0.000848	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Epirubicin—liver cancer	3.6e-05	0.000847	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALDOB—liver cancer	3.59e-05	0.000888	CbGpPWpGaD
Chenodeoxycholic acid—Somnolence—Doxorubicin—liver cancer	3.59e-05	0.000846	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	3.59e-05	0.000888	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Epirubicin—liver cancer	3.57e-05	0.000841	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—CYCS—liver cancer	3.56e-05	0.000881	CbGpPWpGaD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—liver cancer	3.55e-05	0.000837	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—liver cancer	3.51e-05	0.000827	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—UGDH—liver cancer	3.49e-05	0.000864	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—liver cancer	3.48e-05	0.000821	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—liver cancer	3.48e-05	0.00082	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	3.47e-05	0.000857	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Epirubicin—liver cancer	3.47e-05	0.000817	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—liver cancer	3.45e-05	0.000813	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—liver cancer	3.45e-05	0.000813	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Epirubicin—liver cancer	3.45e-05	0.000813	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Epirubicin—liver cancer	3.45e-05	0.000813	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CRABP1—liver cancer	3.42e-05	0.000847	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	3.42e-05	0.000846	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GLUL—liver cancer	3.39e-05	0.00084	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CPT1B—liver cancer	3.39e-05	0.00084	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—liver cancer	3.33e-05	0.000784	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—liver cancer	3.3e-05	0.000778	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—EPT1—liver cancer	3.28e-05	0.000812	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTA3—liver cancer	3.22e-05	0.000796	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Epirubicin—liver cancer	3.21e-05	0.000757	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Doxorubicin—liver cancer	3.21e-05	0.000756	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—liver cancer	3.19e-05	0.000752	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—liver cancer	3.19e-05	0.000752	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Epirubicin—liver cancer	3.13e-05	0.000738	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARA—liver cancer	3.13e-05	0.000774	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TAT—liver cancer	3.11e-05	0.00077	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—HMOX1—liver cancer	3.1e-05	0.000766	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Epirubicin—liver cancer	3.09e-05	0.000727	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.08e-05	0.000763	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	3.08e-05	0.000762	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—HPGDS—liver cancer	2.99e-05	0.000741	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Epirubicin—liver cancer	2.98e-05	0.000703	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.98e-05	0.000736	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—liver cancer	2.97e-05	0.000701	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	2.97e-05	0.000734	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTA4—liver cancer	2.94e-05	0.000728	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Doxorubicin—liver cancer	2.9e-05	0.000682	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Epirubicin—liver cancer	2.88e-05	0.00068	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.88e-05	0.000712	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HNF4A—liver cancer	2.87e-05	0.00071	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTA2—liver cancer	2.87e-05	0.00071	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Doxorubicin—liver cancer	2.86e-05	0.000673	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR1—liver cancer	2.84e-05	0.000701	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	2.81e-05	0.000695	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Epirubicin—liver cancer	2.77e-05	0.000654	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTA1—liver cancer	2.77e-05	0.000685	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—liver cancer	2.76e-05	0.000651	CcSEcCtD
Chenodeoxycholic acid—Rash—Epirubicin—liver cancer	2.75e-05	0.000648	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Epirubicin—liver cancer	2.75e-05	0.000648	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NR1H4—liver cancer	2.74e-05	0.000678	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NAT2—liver cancer	2.74e-05	0.000677	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Epirubicin—liver cancer	2.73e-05	0.000644	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.71e-05	0.000671	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTA3—liver cancer	2.69e-05	0.000666	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.68e-05	0.000662	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Doxorubicin—liver cancer	2.67e-05	0.000629	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSMA4—liver cancer	2.67e-05	0.00066	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSMD10—liver cancer	2.67e-05	0.00066	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	2.66e-05	0.000657	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.63e-05	0.000651	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALDOB—liver cancer	2.62e-05	0.000649	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GOT2—liver cancer	2.6e-05	0.000642	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Epirubicin—liver cancer	2.59e-05	0.000611	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—liver cancer	2.59e-05	0.00064	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Doxorubicin—liver cancer	2.57e-05	0.000605	CcSEcCtD
Chenodeoxycholic acid—Rash—Doxorubicin—liver cancer	2.55e-05	0.0006	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—liver cancer	2.54e-05	0.000599	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—liver cancer	2.53e-05	0.000596	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSMD10—liver cancer	2.51e-05	0.00062	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSMA4—liver cancer	2.51e-05	0.00062	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CRABP1—liver cancer	2.5e-05	0.000619	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—PPARA—liver cancer	2.5e-05	0.000619	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	2.49e-05	0.000616	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTA4—liver cancer	2.46e-05	0.000609	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	2.46e-05	0.000608	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP2E1—liver cancer	2.44e-05	0.000604	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	2.43e-05	0.000601	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTA2—liver cancer	2.4e-05	0.000594	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Doxorubicin—liver cancer	2.4e-05	0.000565	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.36e-05	0.000584	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—SERPINE1—liver cancer	2.33e-05	0.000577	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTA1—liver cancer	2.32e-05	0.000573	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—NAT2—liver cancer	2.29e-05	0.000567	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFB1—liver cancer	2.29e-05	0.000566	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYCS—liver cancer	2.28e-05	0.000565	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	2.26e-05	0.000559	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.25e-05	0.000557	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GGT1—liver cancer	2.24e-05	0.000554	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GOT1—liver cancer	2.24e-05	0.000554	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—HPGDS—liver cancer	2.19e-05	0.000541	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.17e-05	0.000538	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GLUL—liver cancer	2.12e-05	0.000523	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CPT1B—liver cancer	2.12e-05	0.000523	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NR1H4—liver cancer	2.04e-05	0.000505	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	2.02e-05	0.000499	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTP1—liver cancer	2.01e-05	0.000498	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTA3—liver cancer	2.01e-05	0.000496	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—HMOX1—liver cancer	1.98e-05	0.000491	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.98e-05	0.00049	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.96e-05	0.000484	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PSMD10—liver cancer	1.95e-05	0.000482	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PSMA4—liver cancer	1.95e-05	0.000482	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	1.92e-05	0.000475	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GOT2—liver cancer	1.9e-05	0.000469	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ALB—liver cancer	1.86e-05	0.00046	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTM1—liver cancer	1.85e-05	0.000457	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTA4—liver cancer	1.83e-05	0.000454	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—HPGDS—liver cancer	1.83e-05	0.000453	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTA2—liver cancer	1.79e-05	0.000442	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2E1—liver cancer	1.78e-05	0.000441	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1A1—liver cancer	1.75e-05	0.000434	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.73e-05	0.000427	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTA1—liver cancer	1.72e-05	0.000427	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NAT2—liver cancer	1.71e-05	0.000422	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—H2AFX—liver cancer	1.69e-05	0.000419	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—RAF1—liver cancer	1.68e-05	0.000416	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYCS—liver cancer	1.67e-05	0.000413	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GOT1—liver cancer	1.64e-05	0.000405	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GGT1—liver cancer	1.64e-05	0.000405	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALDOB—liver cancer	1.64e-05	0.000404	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—MTHFR—liver cancer	1.63e-05	0.000404	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARA—liver cancer	1.6e-05	0.000397	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CRABP1—liver cancer	1.56e-05	0.000386	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARA—liver cancer	1.51e-05	0.000373	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2E1—liver cancer	1.49e-05	0.000369	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—liver cancer	1.47e-05	0.000365	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	1.47e-05	0.000364	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—liver cancer	1.47e-05	0.000364	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—HMOX1—liver cancer	1.45e-05	0.000359	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.44e-05	0.000356	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MAPK14—liver cancer	1.39e-05	0.000344	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CG—liver cancer	1.37e-05	0.00034	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GGT1—liver cancer	1.37e-05	0.000339	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR1—liver cancer	1.37e-05	0.000338	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HPGDS—liver cancer	1.36e-05	0.000337	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTM1—liver cancer	1.35e-05	0.000334	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARG—liver cancer	1.33e-05	0.000328	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1A1—liver cancer	1.28e-05	0.000317	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARG—liver cancer	1.25e-05	0.000308	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—liver cancer	1.23e-05	0.000305	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSMD10—liver cancer	1.22e-05	0.000301	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSMA4—liver cancer	1.22e-05	0.000301	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	1.21e-05	0.0003	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CD—liver cancer	1.21e-05	0.000299	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—MTHFR—liver cancer	1.19e-05	0.000295	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALB—liver cancer	1.19e-05	0.000295	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GOT2—liver cancer	1.18e-05	0.000292	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARA—liver cancer	1.17e-05	0.00029	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTM1—liver cancer	1.13e-05	0.00028	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SERPINE1—liver cancer	1.12e-05	0.000278	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	1.12e-05	0.000276	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2E1—liver cancer	1.11e-05	0.000275	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1A1—liver cancer	1.07e-05	0.000265	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	1.06e-05	0.000262	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.05e-05	0.00026	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CB—liver cancer	1.05e-05	0.00026	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYCS—liver cancer	1.04e-05	0.000257	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GGT1—liver cancer	1.02e-05	0.000252	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GOT1—liver cancer	1.02e-05	0.000252	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CG—liver cancer	1e-05	0.000248	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARG—liver cancer	9.69e-06	0.00024	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—liver cancer	9.17e-06	0.000227	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HMOX1—liver cancer	9.04e-06	0.000224	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CD—liver cancer	8.82e-06	0.000218	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALB—liver cancer	8.71e-06	0.000215	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTM1—liver cancer	8.42e-06	0.000208	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UGDH—liver cancer	8.02e-06	0.000198	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1A1—liver cancer	7.98e-06	0.000198	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CB—liver cancer	7.69e-06	0.00019	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EPT1—liver cancer	7.54e-06	0.000187	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—MTHFR—liver cancer	7.44e-06	0.000184	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARA—liver cancer	7.3e-06	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TAT—liver cancer	7.15e-06	0.000177	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—liver cancer	7.1e-06	0.000176	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—liver cancer	6.41e-06	0.000159	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CG—liver cancer	6.25e-06	0.000155	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARG—liver cancer	6.04e-06	0.000149	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CD—liver cancer	5.5e-06	0.000136	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALB—liver cancer	5.43e-06	0.000134	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—liver cancer	5.24e-06	0.00013	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—liver cancer	4.92e-06	0.000122	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CPT1B—liver cancer	4.86e-06	0.00012	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GLUL—liver cancer	4.86e-06	0.00012	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CB—liver cancer	4.79e-06	0.000119	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—liver cancer	4.69e-06	0.000116	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NR1H4—liver cancer	4.69e-06	0.000116	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA3—liver cancer	4.61e-06	0.000114	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA4—liver cancer	4.21e-06	0.000104	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA2—liver cancer	4.11e-06	0.000102	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTA1—liver cancer	3.96e-06	9.8e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NAT2—liver cancer	3.92e-06	9.69e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—liver cancer	3.83e-06	9.47e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALDOB—liver cancer	3.76e-06	9.29e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CRABP1—liver cancer	3.58e-06	8.86e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HPGDS—liver cancer	3.13e-06	7.75e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—liver cancer	2.92e-06	7.23e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSMA4—liver cancer	2.79e-06	6.9e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSMD10—liver cancer	2.79e-06	6.9e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GOT2—liver cancer	2.71e-06	6.72e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2E1—liver cancer	2.55e-06	6.31e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYCS—liver cancer	2.39e-06	5.91e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—liver cancer	2.39e-06	5.9e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GOT1—liver cancer	2.34e-06	5.8e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GGT1—liver cancer	2.34e-06	5.8e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—liver cancer	2.11e-06	5.21e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HMOX1—liver cancer	2.08e-06	5.14e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTM1—liver cancer	1.93e-06	4.79e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1A1—liver cancer	1.83e-06	4.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MTHFR—liver cancer	1.71e-06	4.23e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARA—liver cancer	1.68e-06	4.15e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CG—liver cancer	1.44e-06	3.55e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARG—liver cancer	1.39e-06	3.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CD—liver cancer	1.26e-06	3.12e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALB—liver cancer	1.25e-06	3.08e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CB—liver cancer	1.1e-06	2.72e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—liver cancer	6.71e-07	1.66e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—liver cancer	5.48e-07	1.36e-05	CbGpPWpGaD
